STAT+: Pharmalittle: We’re reading about FDA reforming clinical trials, a Pfizer setback, and much more news
Stat News • 6/22/2026 – 6/23/2026
Summary
No summary yet.
Advertisement
Cluster Activity
1
1
2026-06-222026-06-23
Lindy Score Breakdown (V4.2)
3h
Age
1
Sources
from cluster
2
Hours Since Seen
Final Score12/100
CategoryAntiLindy
StatusActive
Recency Multiplier97% (0.5^2/48)
Hero EligibleYes
Story Timeline
- 2026-06-22
- 2026-06-23STAT+: Pharmalittle: We’re reading about FDA reforming clinical trials, a Pfizer setback, and much more news (current)
Score BreakdownRisk 70
Source Reputation: Low-trust source (4/20 pts)
Consensus: Single source - no independent confirmation yet
Age: Breaking news - too recent to assess longevity
Stories gain Lindy status through source reputation, network consensus, and time survival.
Same Story from 2 sources
Breaking Similar stories
STAT+: Pharmalittle: We’re reading about another FDA reversal, pharma’s M&A spree and much more
Stat News • 1 day ago
STAT+: Closely watched Pfizer lung cancer drug falls short in clinical trial
Stat News • Today
STAT+: FDA to launch pilot program to speed up early-stage clinical trials
Stat News • 1 day ago
STAT+: Exclusive: Mystery man gets experimental GLP-1
Stat News • Today
STAT+: OpenEvidence will add FDA-cleared AI to detect heart disease
Stat News • Today
HHS has sent drug for Ebola clinical trial
Stat News • Today
STAT+: Cadence raises $100 million to automate chronic disease care with regulated AI
Stat News • Today
STAT+: Lilly’s retatrutide has been offered to a single person via ‘compassionate use’ program
Stat News • Today
STAT+: A sweeping new AI to detect heart conditions is coming to OpenEvidence
Stat News • Today
STAT+: Pharma goes on a spending spree, snapping up biotechs in a hurry
Stat News • 1 day ago